Very true. If the trial results are not good enough to start a phase 3 trial, then HIV BLA will need to be a priority and us investors deserve a detailed explanation of what the issues are and what the company is doing to fix them. We also need to know when do we expect to re-file again. I got it in back in 16 betting on the HIV to be approved within a couple of years, It is 21 and not even filed yet. But it is ok. I understand that management is doing their best to get it done. We just need some sort of reassurance that it will be filed correctly and in timely manner. It is a little scary that everybody that was supposed to help with this quit.

This company and drug will succeed, we just need to be more patient that we expected to be.